𝔖 Bobbio Scriptorium
✦   LIBER   ✦

EFFECTS OF ADD-ON MIRTAZAPINE ON NEUROCOGNITION IN SCHIZOPHRENIA: AN OPEN LABEL EXTENSION PHASE OF A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY, AND BOTH PHASES

✍ Scribed by Jan H. Stenberg; Viacheslav Terevnikov; Marina Joffe; Jari Tiihonen; Evgueni Tchoukhine; Mark Burkin; Grigori Joffe

Book ID
119365164
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
66 KB
Volume
117
Category
Article
ISSN
0920-9964

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Add-on mirtazapine improves depressive s
Add-on mirtazapine improves depressive symptoms in schizophrenia: a double-blind randomized placebo-controlled study with an open-label extension phase
✍ Viacheslav Terevnikov; Jan-Henry Stenberg; Jari Tiihonen; Marina Joffe; Mark Bur πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 104 KB

Depression is common in schizophrenia and worsens its course. The role of antidepressants for schizophrenic depression remains unclear. In this study, the efficacy of add-on mirtazapine on depression in schizophrenia was explored in a subsidiary arm of a recent randomized controlled trial. Patients

More evidence on additive antipsychotic
More evidence on additive antipsychotic effect of adjunctive mirtazapine in schizophrenia: an extension phase of a randomized controlled trial
✍ Viacheslav Terevnikov; Jan-Henry Stenberg; Marina Joffe; Jari Tiihonen; Mark Bur πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 104 KB

## Abstract ## Objective Adjunctive mirtazapine improved negative symptoms of schizophrenia in several studies. Recently, we found an improvement also in positive symptoms when mirtazapine was added to first generation antipsychotics (FGAs) in a 6 week randomized controlled trial (RCT). The short